Bang Er Orthopedic is a technology company.
Bang Er Orthopedic has raised $50.0M across 2 funding rounds.
Bang Er Orthopedic has raised $50.0M in total across 2 funding rounds.
Bang Er Orthopedic has raised $50.0M in total across 2 funding rounds.
Bang Er Orthopedic's investors include Qiming Venture Partners.
Bang Er Orthopedic is a leading Chinese healthcare company specializing in the investment, operation, and management of orthopedic hospitals and clinics. It primarily builds and operates a network of specialized orthopedic and rehabilitation medical facilities, serving patients with musculoskeletal conditions. The company addresses the growing demand for high-quality orthopedic care by providing advanced surgical and rehabilitative services, significantly improving patient outcomes. With nearly 20 years of development, Bang Er Orthopedic has grown into one of the strongest domestic brands in orthopedic healthcare, operating 14 hospitals and 4 outpatient clinics with a total capacity of about 4,000 beds and performing nearly 20,000 surgeries annually[1][2].
Founded around the early 2000s, Bang Er Orthopedic emerged from Zhejiang Banger Medical Investment Management's initiative to specialize in orthopedic and rehabilitation healthcare. The founders and key management leveraged their expertise in medical investment and hospital operations to build a focused chain of orthopedic hospitals. Over two decades, the company expanded its footprint and capabilities, evolving from a single specialized hospital into a leading hospital group with a strong brand presence in China’s orthopedic sector. Early traction was marked by steady growth in patient volume and surgical procedures, establishing trust and recognition in the market[1][2].
While primarily a healthcare service provider, Bang Er Orthopedic rides the broader trend of specialization and consolidation in medical services, particularly in orthopedics—a field benefiting from technological advances in surgical techniques, rehabilitation, and medical devices. The timing aligns with increasing demand for specialized care driven by aging populations and rising chronic musculoskeletal conditions in China. The company’s scale and specialization position it to influence the healthcare ecosystem by setting standards for orthopedic care quality and operational efficiency, potentially integrating emerging health technologies and data-driven patient management in the future[1][4].
Bang Er Orthopedic is poised for continued growth, especially as it prepares for a public listing, supported by recent substantial pre-IPO funding rounds exceeding $100 million. Future trends shaping its journey include the integration of digital health technologies, expansion of rehabilitation services, and potential geographic expansion beyond Zhejiang province. Its influence is likely to grow as it sets benchmarks for specialized orthopedic care in China, possibly expanding into related healthtech innovations and partnerships. The company’s evolution from a regional specialist to a national leader underscores its strategic positioning in a rapidly modernizing healthcare market[1][4].
Bang Er Orthopedic has raised $50.0M across 2 funding rounds. Most recently, it raised $16.0M Series C in May 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2018 | $16.0M Series C | Qiming Venture Partners | |
| Sep 1, 2017 | $34.0M Series C | Qiming Venture Partners |